Literature DB >> 18926810

Heparin affects matrix metalloproteinases and tissue inhibitors of metalloproteinases circulating in peripheral blood.

Ferdinando Mannello1, Klaus Jung, Gaetana A Tonti, Franco Canestrari.   

Abstract

OBJECTIVES: Blood sampling/handling alters matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) expression. The aim of this study is to evaluate the effects of high molecular weight heparin on MMP and TIMP expression in blood. DESIGN AND METHODS: We analyzed by gelatin zymography and ELISA assays the effects of different heparin salts, dose- and time-dependence of MMP and TIMP concentrations in plasma and sera collected with and without clot-accelerator in plastic tubes from 50 healthy donors.
RESULTS: The levels and zymography of MMP-2 did not show significant changes among all samples, and during time- and dose-dependent heparin treatments. MMP-9 and TIMP-2 expression were strongly affected by heparin, with significant increase of their content and gelatinolytic activity both in time- and in dose-dependent fashion. Addition of heparin allowed also the displacement of MMP-2 prodomain, favouring zymogen activation.
CONCLUSIONS: Heparin has direct and indirect effects, altering MMP/TIMP complexes circulating in blood, and increasing the release of TIMP-2. To avoid misinterpretations due to MMP/TIMP complex alteration and MMP prodomain displacement, heparin should be cautiously used in blood collection procedures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18926810     DOI: 10.1016/j.clinbiochem.2008.09.104

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  7 in total

1.  Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research.

Authors:  Ferdinando Mannello; Joseph D Raffetto
Journal:  Am J Transl Res       Date:  2010-11-23       Impact factor: 4.060

Review 2.  Before you analyze a human specimen, think quality, variability, and bias.

Authors:  Mark David Lim; Anthony Dickherber; Carolyn C Compton
Journal:  Anal Chem       Date:  2010-11-29       Impact factor: 6.986

Review 3.  Matrix metalloproteinases: drug targets for myocardial infarction.

Authors:  Andriy Yabluchanskiy; Yaojun Li; Robert J Chilton; Merry L Lindsey
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

4.  Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles.

Authors:  Klaus Jung; Ferdinando Mannello; Michael Lein
Journal:  J Transl Med       Date:  2009-10-14       Impact factor: 5.531

5.  Matrix metalloproteinases and tissue damage in HIV-tuberculosis immune reconstitution inflammatory syndrome.

Authors:  Rebecca Tadokera; Graeme A Meintjes; Katalin A Wilkinson; Keira H Skolimowska; Naomi Walker; Jon S Friedland; Gary Maartens; Paul T G Elkington; Robert J Wilkinson
Journal:  Eur J Immunol       Date:  2013-10-30       Impact factor: 5.532

6.  In silico analyses of heparin binding proteins expression in human periodontal tissues.

Authors:  Bernadette Lackey; Quentin M Nunes; Susan M Higham; David G Fernig; Sabeel P Valappil
Journal:  BMC Res Notes       Date:  2016-01-28

7.  Discovery of Sulfated Small Molecule Inhibitors of Matrix Metalloproteinase-8.

Authors:  Shravan Morla; Umesh R Desai
Journal:  Biomolecules       Date:  2020-08-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.